FY2026 EPS Estimates for CME Group Boosted by Zacks Research

CME Group Inc. (NASDAQ:CME) – Equities researchers at Zacks Research raised their FY2026 earnings per share (EPS) estimates for shares of CME Group in a research report issued on Tuesday, February 4th. Zacks Research analyst T. De now expects that the financial services provider will post earnings of $10.80 per share for the year, up from their prior forecast of $10.74. The consensus estimate for CME Group’s current full-year earnings is $10.18 per share. Zacks Research also issued estimates for CME Group’s Q4 2026 earnings at $2.95 EPS.

A number of other research firms have also weighed in on CME. Oppenheimer boosted their target price on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Piper Sandler raised their target price on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft cut their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Finally, Morgan Stanley boosted their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $229.27.

CME Group Trading Down 0.4 %

CME stock opened at $241.64 on Thursday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a one year low of $190.70 and a one year high of $249.02. The company’s 50 day moving average price is $235.20 and its two-hundred day moving average price is $223.49. The company has a market capitalization of $87.08 billion, a PE ratio of 25.41, a price-to-earnings-growth ratio of 5.37 and a beta of 0.57.

CME Group Increases Dividend

The company also recently declared a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were paid a $5.80 dividend. This is a boost from CME Group’s previous dividend of $2.50. The ex-dividend date was Friday, December 27th. CME Group’s dividend payout ratio is 48.37%.

CME Group announced that its Board of Directors has initiated a stock buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its shares are undervalued.

Hedge Funds Weigh In On CME Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Plato Investment Management Ltd grew its stake in shares of CME Group by 3.1% during the fourth quarter. Plato Investment Management Ltd now owns 15,860 shares of the financial services provider’s stock worth $3,697,000 after purchasing an additional 470 shares in the last quarter. SBI Securities Co. Ltd. purchased a new position in shares of CME Group during the 4th quarter worth approximately $390,000. Jones Financial Companies Lllp boosted its position in shares of CME Group by 45.0% during the 4th quarter. Jones Financial Companies Lllp now owns 4,575 shares of the financial services provider’s stock worth $1,062,000 after purchasing an additional 1,419 shares in the last quarter. Modera Wealth Management LLC grew its position in CME Group by 2.3% during the fourth quarter. Modera Wealth Management LLC now owns 4,817 shares of the financial services provider’s stock worth $1,119,000 after buying an additional 110 shares during the period. Finally, SRS Capital Advisors Inc. increased its stake in CME Group by 7,056.5% in the 4th quarter. SRS Capital Advisors Inc. now owns 1,646 shares of the financial services provider’s stock valued at $382,000 after purchasing an additional 1,623 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.